X0306 4 2021-06-15 0 0001819790 Tarsus Pharmaceuticals, Inc. TARS 0001791249 Ackermann Michael C/O TARSUS PHARMACEUTICALS, INC. 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618 1 0 0 0 Common Stock 2021-06-15 4 A 0 4257 0.00 A 1233181 D Stock Option (right to buy) 35.26 2021-06-15 4 A 0 10000 0.00 A 2031-06-15 Common Stock 10000 10000 D Stock Option (right to buy) 35.26 2021-06-15 4 A 0 10000 0.00 A 2031-06-15 Common Stock 10000 10000 D Restricted Stock Units 2021-06-15 4 A 0 4257 0.00 A Common Stock 4257 4257 D The Reporting Person was granted restricted stock units ("RSUs") in connection with the Reporting Person's service as a non-employee director as of the closing of the Company's initial public offering and continued service as of the Company's 2021 annual meeting of stockholders. The RSUs are fully vested as of the date of grant. Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2021 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Option granted in connection with the Reporting Person's service as a non-employee director as of the closing of the Company's initial public offering and continued service as of the Company's 2021 annual meeting of stockholders. The option is fully vested. Each RSU represents a contingent right to receive one share of the Company's common stock. RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2021 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. /s/ Leo Greenstein 2021-06-17